Structural Formula (Image 1)
Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 0093-5347
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 0093-5347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 2)
This is a table showing the mean di-methylphenidate plasma levels (measured in ng/mL) for two groups of participants. The first group of 17 people took 40mg of methylphenidate HCl extended-release once a day and the second group of 16 people took 20mg of methylphenidate twice a day.*
Figure 2 (Image 3)
0093-5346-01 20 mg 100s (Image 4)
Methylphenidate Hydrochloride Extended-Release Capsules (LA) are available in a pack of 100 capsules. Each capsule contains 20mg of methylphenidate hydrochloride and is intended for once daily use. The medication guide should be provided to each patient by the pharmacist. The dosage should be as recommended in the package insert. The capsules should be stored at controlled room temperature, in a tightly closed, light-resistant container, away from children. The manufacturer is Teva Pharmaceuticals USA. Lot/exp number is 0093-5346-01 239508.*
0093-5347-01 30 mg 100s (Image 5)
This is a medication with NDC code 0093-5347-01, containing Methylphenidate hydrochloride in extended-release capsules of 30mg. This medication should be prescribed by doctors, and the patients must receive an accompanying medication guide. Each package contains 100 capsules, and the recommended storage temperature is between 20-25°C. This medication must be kept in a light-resistant and child-resistant container. The manufacturer is TEVA Pharmaceuticals USA, Inc, located in North Wales, PA. The medication usage should follow the package insert's instructions.*
0093-5348-01 40 mg 100s (Image 6)
This is a medication guide for Methylphenidate Hydrochloride Extended-Release Capsules (LA) with strength of 40mg taken once daily. The capsules contain methylphenidate hydrochloride and are to be stored at 20° to 25°C (68° to 77°F). The container must be kept out of the reach of children. The manufacturer is Teva Pharmaceuticals USA, Inc located in North Wales, PA 18454. The usual dosage must be obtained from the package insert. The NDC number is 0093-5348-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
